Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Shares Issued (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Shares Issued for 15 consecutive years, with $122000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 39.9% to $122000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $216000.0 through Dec 2025, down 98.04% year-over-year, with the annual reading at $216000.0 for FY2025, 98.04% down from the prior year.
  • Shares Issued hit $122000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from $88000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $10.1 million in Q1 2024 to a low of $6000.0 in Q1 2025.
  • Historically, Shares Issued has averaged $2.6 million across 5 years, with a median of $1.5 million in 2022.
  • Biggest five-year swings in Shares Issued: soared 820.0% in 2021 and later crashed 99.94% in 2025.
  • Year by year, Shares Issued stood at $5.5 million in 2021, then tumbled by 49.39% to $2.8 million in 2022, then plummeted by 64.43% to $998000.0 in 2023, then plummeted by 79.66% to $203000.0 in 2024, then plummeted by 39.9% to $122000.0 in 2025.
  • Business Quant data shows Shares Issued for IRWD at $122000.0 in Q4 2025, $88000.0 in Q2 2025, and $6000.0 in Q1 2025.